September 24, 2019 by BioHouston Salarius Pharmaceuticals Achieves Dose-Escalation Milestones in Ongoing Phase 1/2 Ewing Sarcoma and Phase 1 Advanced Solid Tumor Clinical Trials
September 20, 2019 by BioHouston Texas Medical Center Selected for $5 million CPRIT Grant for New Cancer Therapeutics Program
September 19, 2019 by BioHouston Castle Biosciences Added to Membership of US Small-Cap Russell 2000® Index
September 16, 2019 by BioHouston Pulmotect Announces Election of Dr. Kumar Srinivasan to the Board of Directors
September 10, 2019 by BioHouston Lexicon Pharmaceuticals Announces Termination of Alliance And Settlement With Sanofi
August 28, 2019 by BioHouston Texas-Based Cancer Insight Helps Clients Obtain $31 Million in CPRIT Funding Thus Far in 2019